Home detoxification from alcohol: Its safety and efficacy in comparison with inpatient care
Authors: Stockwell, T., Bolt, L., Milner, I., Russell, G., Bolderston, H. and Pugh, P.
Journal: Alcohol and Alcoholism
Volume: 26
Issue: 5-6
Pages: 645-650
ISSN: 0735-0414
DOI: 10.1093/oxfordjournals.alcalc.a045169
Abstract:The safety and short-term effectiveness of home detoxification (HD) was investigated by contrasting rates of treatment completion and of complications of 41 service users with those of a retrospectively matched inpatient comparison group. The latter comprised patients of a detoxification unit matched for age, sex and degree of alcohol dependence with HD subjects. HD subjects had severe problems with alcohol-they averaged 28.7 on the SADQ, 4.6 serious alcohol-related problems in the previous 2 months, a GGT of 123.8 and 174.6 reported units of alcohol consumed in the week before treatment. A high follow-up rate was achieved for both HD subjects and their relatives; there was close agreement between clients' reports, carers' reports and breathalyser readings with regard to further alcohol consumption. The HD subjects were visited at home an average of 6 9 times over 6.15 days. Chlormethiazole was prescribed in 36 cases at an average maximum daily dose of 6.3 capsules - significantly fewer than for the inpatient group. Both rates of completion and complication were virtually identical in the 2 groups. It is concluded that these data suggest HD is equivalent in both its safety and immediate efficacy to more expensive inpatient care. © 1991 Medical Council on Alcoholism.
Source: Scopus
Home detoxification from alcohol: its safety and efficacy in comparison with inpatient care.
Authors: Stockwell, T., Bolt, L., Milner, I., Russell, G., Bolderston, H. and Pugh, P.
Journal: Alcohol Alcohol
Volume: 26
Issue: 5-6
Pages: 645-650
ISSN: 0735-0414
DOI: 10.1093/oxfordjournals.alcalc.a045169
Abstract:The safety and short-term effectiveness of home detoxification (HD) was investigated by contrasting rates of treatment completion and of complications of 41 service users with those of a retrospectively matched inpatient comparison group. The latter comprised patients of a detoxification unit matched for age, sex and degree of alcohol dependence with HD subjects. HD subjects had severe problems with alcohol--they averaged 28.7 on the SADQ, 4.6 serious alcohol-related problems in the previous 2 months, a GGT of 123.8 and 174.6 reported units of alcohol consumed in the week before treatment. A high follow-up rate was achieved for both HD subjects and their relatives; there was close agreement between clients' reports, carers' reports and breathalyser readings with regard to further alcohol consumption. The HD subjects were visited at home an average of 6.9 times over 6.15 days. Chlormethiazole was prescribed in 36 cases at an average maximum daily dose of 6.3 capsules--significantly fewer than for the inpatient group. Both rates of completion and complication were virtually identical in the 2 groups. It is concluded that these data suggest HD is equivalent in both its safety and immediate efficacy to more expensive inpatient care.
Source: PubMed
Home detoxification from alcohol: its safety and efficacy in comparison with inpatient care.
Authors: Stockwell, T., Bolt, L., Milner, I., Russell, G., Bolderston, H. and Pugh, P.
Journal: Alcohol and alcoholism (Oxford, Oxfordshire)
Volume: 26
Issue: 5-6
Pages: 645-650
eISSN: 1464-3502
ISSN: 0735-0414
DOI: 10.1093/oxfordjournals.alcalc.a045169
Abstract:The safety and short-term effectiveness of home detoxification (HD) was investigated by contrasting rates of treatment completion and of complications of 41 service users with those of a retrospectively matched inpatient comparison group. The latter comprised patients of a detoxification unit matched for age, sex and degree of alcohol dependence with HD subjects. HD subjects had severe problems with alcohol--they averaged 28.7 on the SADQ, 4.6 serious alcohol-related problems in the previous 2 months, a GGT of 123.8 and 174.6 reported units of alcohol consumed in the week before treatment. A high follow-up rate was achieved for both HD subjects and their relatives; there was close agreement between clients' reports, carers' reports and breathalyser readings with regard to further alcohol consumption. The HD subjects were visited at home an average of 6.9 times over 6.15 days. Chlormethiazole was prescribed in 36 cases at an average maximum daily dose of 6.3 capsules--significantly fewer than for the inpatient group. Both rates of completion and complication were virtually identical in the 2 groups. It is concluded that these data suggest HD is equivalent in both its safety and immediate efficacy to more expensive inpatient care.
Source: Europe PubMed Central